Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 19, 2020– Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on addressing key...
Aptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s Disease NYX-458 is currently under evaluation in a Phase 2 study in patients with mild cognitive impairment associated...
Aptinyx Announces Pricing of Public Offering of Common Stock EVANSTON, Ill., Jan. 10, 2020 (GLOBE NEWSWIRE) — Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system...
Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering on product support, customer loyalty and...
BrightInsight Announces Global Digital Health Partnership with AstraZeneca AstraZeneca selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment SAN JOSE, Calif., March 25, 2020 (GLOBE NEWSWIRE)...
Recent Comments